Physicians and the prescription of hormone replacement therapy in Spain

Hormonal contraception and postmenopausal hormone therapy in Spain

“…8,9 A cross-sectional telephone survey in 2002 observed that 22.3% of women aged 45 to 65 years had ever been prescribed HT, using a sample from the reference population of a primary healthcare center. 19 Among those prescribed HT, compliance was 44.2%, which is comparable to our findings (HT use of 9.9%). Other studies were based on pharmacy sales data, 20,21 whereas others were less representative of the Spanish population, as a study carried out among symptomatic postmenopausal women showed a prevalence of HT use of 67%.…”

Anthropometric and gynaecological history according to the socioeconomic status of postmenopausal women: poverty and the menopause

“…46–48 In a study performed in Italy, higher education was associated with an increased frequency of HRT use in comparison with women reporting no, or primary/middle-school, education. 49 Similar results have also been described in Norway, 50 the United States, 51 Spain 52 and the United Kingdom. 53…”

Use of hormone therapy and isoflavones and mammographic density in Spain

“…In 2002, it was proven that the use of estrogen plus progestogens (estrogen plus progestogen therapy [EPT]) was associated with an increased risk of breast cancer, 1 and, accordingly, its use has diminished both internationally 2,3 and in our country. 4,5 HT use varies with age, socioeconomic status, and education level, as well as several lifestyle factors. [6][7][8] Numerous studies have pointed out that the most common mammographic change that postmenopausal women experience after receiving HT is an increase in mammographic density (MD), [9][10][11] considered the main phenotype risk marker for breast cancer.…”